REVEALPLAQUE

A pRospEctiVe, multicEnter study to AnaLyze PLAQUE using CCTA

Objective

This study will evaluate the level of agreement between this noninvasive CCTA-based quantification and characterization of coronary atherosclerosis and invasive IVUS.

Eligibility

• Age ≥18 years
• Clinically stable patient with known CAD
• CCTA showing stenosis in at least one major epicardial vessel of stentable/graftable diameter, in whom clinically indicated IVUS is planned within 45 days of the CCTA and FFRCT available
• FFRCT successfully processed
• Willing to comply with all aspects of the protocol
• Agrees to be included in the study and able to provide written informed consent.

NCT ID

NCT05138289